دورية أكاديمية
أعرض في EDS

Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

التفاصيل البيبلوغرافية
العنوان: Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis
المؤلفون: G. Andrisani, E. Gremese, L. Guidi, A. Papa, M. Marzo, C. Felice, D. Pugliese, A. Armuzzi
المصدر: Reumatismo, Vol 65, Iss 2, Pp 75-78 (2013)
بيانات النشر: PAGEPress Publications, 2013.
سنة النشر: 2013
المجموعة: LCC:Medicine
LCC:Internal medicine
مصطلحات موضوعية: Ulcerative colitis, Rheumatoid arthritis, Adalimumab., Medicine, Internal medicine, RC31-1245
الوصف: Inflammatory bowel disease (IBD) is commonly associated with peripheral inflammatory arthritis, and it has been estimated that as many as 12% of IBD patients report these manifestations. However, rheumatoid arthritis (RA) is rarely associated with ulcerative colitis (UC). Among all the biological agents available, nine have been currently approved for the treatment of RA. Conversely, only Infliximab and recently Adalimumab have been approved for UC. In particular, the efficacy of Adalimumab in UC has been demonstrated by both recent randomized controlled trials and real-life studies. Moreover, Adalimumab is a well-established treatment for RA. Herein, we describe a patient with RA and UC treated successfully with ADA.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
Italian
تدمد: 0048-7449
2240-2683
Relation: http://www.reumatismo.org/index.php/reuma/article/view/648; https://doaj.org/toc/0048-7449; https://doaj.org/toc/2240-2683
DOI: 10.4081/reumatismo.2013.75
URL الوصول: https://doaj.org/article/e55118c5592a46779678e93b1ec3dfc1
رقم الأكسشن: edsdoj.55118c5592a46779678e93b1ec3dfc1
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00487449
22402683
DOI:10.4081/reumatismo.2013.75